Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

dc.contributor.author	Kahraman, Resul
dc.contributor.author	Calhan, Turan
dc.contributor.author	Sahin, Abdurrahman
dc.contributor.author	Ozdil, Kamil
dc.contributor.author	Caliskan, Zuhal
dc.contributor.author	Bireller, Elif Sinem
dc.contributor.author	Cakmakoglu, Bedia
dc.date.accessioned	2021-12-21T08:46:48Z
dc.date.available	2021-12-21T08:46:48Z
dc.date.issued	2017
dc.identifier.issn	1178-203X
dc.identifier.uri	https://doi.org/10.2147/TCRM.S140618
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2100
dc.description.abstract	This study examined the adiponectin and leptin levels and insulin resistance (IR) in patients with inflammatory bowel disease (IBD) and the associations between these factors and IBD characteristics. Fasting serum leptin, adiponectin, glucose, and insulin
dc.language.iso	English
dc.publisher	Dove Medıcal Press Ltd
dc.rights	Green Published, gold, Green Submitted
dc.title	Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?
dc.type	Article
dc.relation.journal	Therapeutıcs And Clınıcal Rısk Management
dc.identifier.startpage	1295
dc.identifier.endpage	1301
dc.identifier.volume	13
dc.identifier.doi	10.2147/TCRM.S140618
dc.relation.volume	13

Files in this item

Files	Size	Format	View
There are no files associated with this item.